Table 2.
Interquartile analysis according to age, midregional pro-adrenomedullin (MR-proADM), and high-sensitivity troponin T (hsTnT) values
| Parameter | Deceased | Survived | p | CV events | Others | p (χ2) |
|---|---|---|---|---|---|---|
| Age | ||||||
| Upper quartile (≥77.0) | 4 (44.4) | 15 (21.4) | 0.26 | 5 (35.7) | 14 (21.5)† | 0.43 |
| Others | 5 (55.6) | 55 (78.6) | 9 (64.3) | 51 (78.5) | ||
| MR-proADM | ||||||
| Upper quartile | 6 (66.7) | 14 (20.0) | <0.01 | 9 (64.3) | 11 (16.9) | <0.01 |
| Others | 3 (33.3) | 56 (80.0) | 6 (35.7) | 54 (83.1) | ||
| hsTNT | ||||||
| Upper quartile (≥10.8) | 4 (44.4) | 15 (21.4) | 0.26 | 6 (42.9) | 13 (20.0) | 0.14 |
| Others | 5 (55.6) | 55 (78.6) | 8 (57.1) | 52 (80.0) | ||
| MR-proADM | ||||||
| <0.85 | 1 (11.1) | 56 (80.0) | <0.01 | 4 (28.6) | 55 (84.6) | <0.01 |
| ≥0.85 | 8 (88.9) | 14 (20.0) | 10 (71.4) | 10 (15.4) | ||
| hsTNT | ||||||
| <7.5 | 4 (44.4) | 24 (34.3) | 0.38 | 6 (42.9) | 45 (69.3) | 0.11 |
| ≥7.5 | 5 (55.6) | 46 (65.7) | 8 (57.1) | 20 (30.7) | ||
| MR-proADM | ||||||
| PPV | 0.301 | 0.362 | 0.451 | 0.502 | ||
| 95% CI | 0.18–0.45 | 0.25–0.49 | 0.29–0.62 | 0.34–0.66 | ||
| NPV | 0.95 | 0.98 | 0.90 | 0.93 | ||
| 95% CI | 0.88–0.98 | 89.8–99.7 | 0.83–0.94 | 0.86–0.96 | ||
| hsTNT | ||||||
| PPV | 0.21 | 0.10 | 0.32 | 0.29 | ||
| 95% CI | 0.10–0.38 | 0.06–0.17 | 0.18–0.50 | 0.18–0.42 | ||
| NPV | 0.92 | 0.86 | 0.87 | 0.88 | ||
| 95% CI | 0.86–0.95 | 0.73–0.93 | 0.80–0.91 | 0.80–0.93 |
Numbers of patients (%) are shown except for positive (PPV) and negative predictive values (NPV). CV, cardiovascular.
1
PPV and NPV were calculated based on upper quartiles of MR-proADM and hsTnT, respectively.
2
PPV and NPV were calculated based on specific values of MR-proADM (≥0.85) and hs TnT (≥7.5), respectively.